Clinical characteristics of patients with a false-negative axillary node evaluation by LymphPET and ultrasound
| Patient ID | Age (years) | Side | Operation | MG | Location | Size cm | Histology | Grade | LV | ER% | PR% | HER2 | Ki67 | No SLN removed | No. lymph node macrometastases | AD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 | 44 | Right | M | Mass | Center | 1.5 | IDC | III | + | 80 | 60 | + | 15 | 4 | 1 | 0/19 |
| 76 | 67 | Right | BCS | MC | Outer upper | 3.7 | IDC | II | – | 80 | 10 | + | 20 | 3 | 1 | 0/12 |
| 83 | 41 | Right | M | MC | Outer upper | 1.5 | IDC | II | + | 80 | 80 | – | 15 | 5 | 2 | 0/15 |
| 116 | 67 | Right | M | MC | Outer upper | 2.8 | IDC | II | + | 80 | 80 | – | 10 | 6 | 3 | 0/12 |
| 117 | 41 | Right | BCS | Mass | Outer upper | 3 | IDC | II | + | 80 | 80 | – | 30 | 3 | 2 | 2/20 |
| 128 | 69 | Right | M | Mass | Inner upper | 2 | ILC | II | – | 80 | 20 | – | 30 | 3 | 2 | 6/24 |
| 129 | 47 | Left | M | Mass | Outer | 2.2 | IDC | II | + | 80 | 80 | – | 10 | 4 | 2 | 0/25 |
| 144 | 57 | Left | M | Mass | Outer lower | 3.5 | IDC | II | + | 80 | 80 | – | 30 | 3 | 1 | 1/22 |
| 147 | 61 | Right | M | Mass | Outer upper | 1.2 | IDC | II | – | 0 | 0 | – | 80 | 4 | 1 | 0/8 |
AD, axillary dissection; BCS, breast-conserving surgery; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LV, lymphovascular invasion; M, mastectomy; MC, mass with calcification; MG, mammography.